Transitions, the Transitions logo, and Transitions Light Intelligent Technology are trademarks of Transitions Optical, Inc. used under license by Transitions Optical Limited and Johnson & Johnson Vision Care, Inc.
FOOTNOTES
~Compared to ACUVUE® OASYS with HYDRACLEAR® PLUS
**ClinicalTrials.gov is a website maintained by the NIH. The 22 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand 2- week family contact lenses vs. competitors’ products. Review conducted as of April 30, 2023. +Defined as high intensity light/bright light/changing light found both indoors and outdoors.
±Calculated per ISO-8980-3 for 380-460nm (Blue Light Hazard Function, β(λ))
*These measures are calculated within the range where you have the highest energy across the blue light hazard.
∞Filtering of HEV light by contact lenses has not been demonstrated to confer any health benefit to the user, including but not limited to retinal protection,
protection from cataract progression, reduced eye strain, improved contrast, improved acuity, reduced glare, improved low light vision, or improved circadian
rhythm/sleep cycle. The Eye Care Professional should be consulted for more information.
#Helps protect against transmission of harmful UV radiation to the cornea & into the eye.
^WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care professional for more information.
†Defined as the ability to see comfortably in bright light.
¥ACUVUE® OASYS with TransitionsTM provides visual comfort by delivering superior ability to see comfortably and superior reduction of squinting when using digital devices, compared to ACUVUE® OASYS with HYDRACLEAR® PLUS
βClinical trials have shown those aged 40-65 may be more likely to experience this benefit in the inactivated ACUVUE® OASYS with TransitionsTM lens.
REFERENCES
1. Scales C, Mohammed C. T-CSM VIS-TD-104656/3: Definition of ACUVUE® OASYS with Transitions[^TM Light Intelligent TechnologyTM.
2. Clark M, Scales C. T-CSM VIS-TD-102880/2: Material Properties: ACUVUE® OASYS Brand Contact Lenses with HYDRACLEAR® Plus, ACUVUE® OASYS with TransitionsTM Light Intelligent TechnologyTM, and Other Reusable Contact Lenses.
3. FDA press release: FDA clears first contact lens with light-adaptive technology https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm604263.hTM (accessed Apr 10, 2018).
4. JJV Data on File 2018: JJV Data on File 2018: Blaring Light Market Research
5. JJV Data on File 2018: ACUVUE® OASYS Brand Contact Lenses with TransitionsTM Light Intelligent TechnologyTM - Objective Clinical.
6. JJV Data on File 2018. ACUVUE® OASYS with TransitionsTM Objective and Subjective Clinical
7. JJV Data on File 2018. ACUVUE® OASYS with TransitionsTM Subjective Clinical Evaluation of two silicone hydrogel reusable contact lenses, 6-week dispensing evaluation, n=239 soft contact lens wearers in the US.
8. JJV Data on File 2018: Material Properties: ACUVUE® OASYS Brand Contact Lenses with HYDRACLEAR® Plus, ACUVUE® OASYS with TransitionsTM Light Intelligent TechnologyTM, and Other Reusable Contact Lenses.
9. JJV Data on File 2018. Definition of ACUVUE® OASYS with TransitionsTM Light Intelligent TechnologyTM.
10. Wygonik E, Franklin N. CSM VIS-TD-104988/5: ACUVUE® OASYS Brand Contact Lenses with TransitionsTM Light Intelligent TechnologyTM - Objective Clinical Claims.
11. Lasky J. VIS-TD-109205/1: Competitive Intelligence Search Results for Transition Technologies. 2022.
12. JJV Data on File 2020. ACUVUE® OASYS Family Digital Device Claims.
13. JJV Data on File 2019. ACUVUE® OASYS Contact Lenses with TransitionsTM Light Intelligent TechnologyTM - Subjective Clinical Claims.
14. JJV Data on File 2018. ACUVUE® OASYS with TransitionsTM Subjective Clinical Evaluation of two silicone hydrogel reusable contact lenses, 6-week dispensing evaluation, n=109 soft contact lens wearers in the US.
15. JJV Data on File 2018: ACUVUE® OASYS with TransitionsTM Objective Clinical
16. JJV Data on File 2018. ACUVUE® Master Brand Claims on Clinical Performance and Overall Material Properties.
17. JJV Data on File 2018. Similarities between Mucin and Poly(N- Vinyl Pyrrolidone) (PVP).
18. Fadli Z, Mahadevan S, Scales C. Antioxidant Capacity of a Phenolic Benzotriazole (Norbloc) in Soft Contact Lens Materials: A Benefit Beyond UV Blocking. Invest. Ophthalmol. Vis. Sci. 2018;59:1759.
PP2023MLT6360